nRichDX
nRichDX is a biotechnology company specializing in liquid biopsy sample preparation. Their patented Revolution™ System is designed to extract significantly more target material, such as ctDNA and CTCs, compared to existing methods, addressing the critical issue of insufficient analyte yield that can lead to inaccurate diagnostic results in molecular testing. The platform offers a high-yield, IVD-labeled solution capable of processing a wide range of sample volumes (1 mL-50 mL) and accommodating multiple specimen types and targets. By enhancing test sensitivity and reliability, nRichDX aims to facilitate earlier disease detection, monitoring, and optimal patient outcomes in the precision medicine market.
nRichDX
nRichDX is a biotechnology company specializing in liquid biopsy sample preparation. Their patented Revolution™ System is designed to extract significantly more target material, such as ctDNA and CTCs, compared to existing methods, addressing the critical issue of insufficient analyte yield that can lead to inaccurate diagnostic results in molecular testing. The platform offers a high-yield, IVD-labeled solution capable of processing a wide range of sample volumes (1 mL-50 mL) and accommodating multiple specimen types and targets. By enhancing test sensitivity and reliability, nRichDX aims to facilitate earlier disease detection, monitoring, and optimal patient outcomes in the precision medicine market.